Phisoderm Gel
FDA Label NDC 10742-1235

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by The Mentholatum Company for the product Phisoderm (NDC 10742-1235). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredient, purpose, uses, warnings, when using this product, if pregnant or breast-feeding,, keep out of reach of children., directions, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Active Ingredient

Salicylic acid 2%

Purpose

Acne treatment

Uses

  • For the treatment of acne

Warnings

For external use only

When Using This Product

  • avoid contact with eyes. If contact occurs, flush thoroughly with water.
  • skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.

If Pregnant Or Breast-Feeding,

ask a health professional before use.

Keep Out Of Reach Of Children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

  • wet face, then gently massage cleanser onto skin
  • rinse well and pat dry
  • use twice daily

Inactive Ingredients

water, lauramidopropyl betaine, sodium C14-16 olefin sulfonate, lauryl glucoside, aloe barbadensis leaf juice, aminomethyl propanol, butylene glycol, caprylyl/capryl glucoside, carica papaya (papaya) fruit extract, chamomilla recutita (matricaria) flower extract, disodium EDTA, fragrance, glycerin, hydroxyphenyl propamidobenzoic acid, hydroxypropyltrimonium hyaluronate, pentylene glycol, potassium sorbate, sodium benzoate, sodium chloride, tocopheryl acetate [vitamin E]

Questions?

1-877-636-2677 MON-FRI 9 AM to 5 PM (EST)

* Please review the disclaimer below.